Search

Editors

Harry Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Richard L. Cassin Editor at Large

Elizabeth K. Spahn Editor Emeritus 

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in Pfizer (32)

Thursday
Feb282019

Giant corporations are good for compliance

Most of us, if we have any sense at all, harbor some healthy distrust of the world's biggest companies. For good reason we fear the concentrated power of giant corporations. What, after all, is one person compared to the overwhelming might of Facebook, Walmart, or Exxon?

Click to read more ...

Monday
Sep172018

Job: Senior Corporate Counsel, Anti-Corruption Program Office

Job Title: Senior Corporate Counsel, Anti-Corruption Program Office

Employer: Pfizer Inc.

Location: New York, New York USA

Click to read more ...

Thursday
Nov122015

DOJ to companies: New compliance counsel provides a ‘reality check’

The Department of Justice Fraud Section said this month it has hired Hui Chen as a “full-time compliance expert.”

Click to read more ...

Tuesday
Mar032015

How do pharmas pay bribes? The SEC counts the ways

In a speech Tuesday at CBI's Annual Pharmaceutical Compliance Congress in Washington D.C., the head of the SEC's enforcement division, Andrew Ceresney, left, talked about the most common ways pharmas violate the FCPA.

Click to read more ...

Friday
Dec262014

Avon disgorgement lands on top ten list

Image courtesy of AvonAvon's $135 million settlement with the DOJ and SEC earlier this month included a disgorgement to the SEC with interest that ranks 8th on our list of the biggest FCPA disgorgements.

Click to read more ...

Tuesday
Nov042014

Bio-Rad cracks the disgorgement top ten list

Bio-Rad Laboratories paid a total of $55 million Monday to settle FCPA offenses. About $40 million of that went to the SEC as disgorgement. That payment landed tenth on our list of the biggest FCPA-related disgorgements.

Click to read more ...

Monday
Jul072014

Job: Senior Corporate Counsel, Transactions Compliance Lead (Pfizer)

Job Title: Senior Corporate Counsel, Transactions Compliance Lead

Employer: Pfizer

Location:New York, NY

Click to read more ...

Thursday
May082014

Most Saudis think graft, nepotism are on the rise

A survey by Saudi Arabia's National Anti-Corruption Commission found that 67.8 percent of the respondents believe financial and state corruption is on the rise in the country.

Click to read more ...

Thursday
Apr102014

Correction: H-P disgorgement is 11th biggest

Hewlett-Packard's $108 million settlement this week didn't quite make our list of the top ten FCPA cases of all time. But with a disgorgement to the SEC of $26.4 million, H-P landed eleventh on the list of the biggest FCPA disgorgements.

Click to read more ...

Monday
Mar032014

DOJ declination for Merck

Big-pharma Merck said an SEC filing Thursday that the DOJ has closed its FCPA investigation of the company.

Click to read more ...

Friday
Jan102014

Alcoa disgorgement is third biggest in FCPA history 

As part of its $354 million settlement this week, Alcoa agreed to pay the third biggest disgorgement in FCPA history -- $161 million.

Click to read more ...

Friday
Oct182013

U.S., China enforcement crossfire creates new risks

At the beginning of this year, China's president Xi Jinping promised to fight both "tigers" and "flies" -- high-ranking and low-ranking corrupt officials -- in his crackdown on corruption. Since then, the anti-graft campaign has led to the conviction of Bo Xilai and to the front-page investigations of foreign companies in the pharmaceutical and oil and gas sectors, among others.

Click to read more ...